1 – 10 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Pharmaceutical Industry Payments to Patient Organizations in Poland : Analysis of the Patterns, Evolution, and Structure of Connections
2025) In International journal of social determinants of health and health services 55(2). p.199-212(
- Contribution to journal › Article
-
Mark
Unknowns of drug company payment disclosure : why the UK needs payment transparency legislation
2025) In BMJ Evidence-Based Medicine(
- Contribution to journal › Article
-
Mark
Self-regulation of UK's pharmaceutical industry
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Det är dags att Läkartidningen slutar med läkemedelsannonser
2025) In Läkartidningen(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed
(
- Contribution to journal › Article
- 2024
-
Mark
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation
(
- Contribution to journal › Article
-
Mark
Patterns of company misconduct, recidivism, and complaint resolution delays : A temporal analysis of UK pharmaceutical industry self-regulation within the European context
2024) In Regulation and Governance(
- Contribution to journal › Article
-
Mark
Läkares jäv bör redovisas i media
2024) In Dagens Media(
- Contribution to specialist publication or newspaper › Newspaper article
-
Mark
Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States : A comparative study of accelerated approvals
(
- Contribution to journal › Article
-
Mark
Broken beyond repair: self regulation of industry payments to clinicians and hospitals
(
- Contribution to journal › Debate/Note/Editorial